Orphenadrine Citrate, Aspirin and Caffeine
- Product NDC
- 71993-307
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Orphenadrine Citrate, Aspirin and Caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Atland Pharmaceuticals, LLC
- Application
- ANDA075141
- Marketing category
- ANDA
- Substance
- ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
- Current FDA listing
- Yes
Related Records
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|---|---|---|---|---|
| 71993-307-60 | 60 TABLET in 1 BOTTLE, PLASTIC (71993-307-60) | 2023-03-01 | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|---|---|---|---|
| Orphenadrine Citrate, Aspirin and Caffeine tablets 50 mg/ 770 mg/ 60 mg USP | Atland Pharmaceuticals, LLC | 2025-10-17 | HUMAN PRESCRIPTION DRUG LABEL | 6 |
| Orphenadrine Citrate, Aspirin and Caffeine tablets 50 mg/ 770 mg/ 60 mg USP | Atland Pharmaceuticals, LLC | 2025-01-13 | HUMAN PRESCRIPTION DRUG LABEL | 5 |